Mount Sinai’s Cancer AI Spinout PreciseDx Targets Early Parkinson’s Detection

Mount Sinai Health System’s recently launched digital pathology offshoot, PreciseDx, was created to support prostate and breast cancer diagnoses. Now, early detection of Parkinson’s disease has also been found to be possible through its advanced AI programs...